Ocean Biomedical, Inc. (OCEA)
OTCMKTS · Delayed Price · Currency is USD
0.0010
+0.0002 (25.00%)
Sep 8, 2026, 1:56 PM EST
Ocean Biomedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | - | - | 0 | 0.03 | 0.06 | - |
Cash & Short-Term Investments | - | - | 0 | 0.03 | 0.06 | - |
Cash Growth | - | - | -88.23% | -43.33% | - | - |
Prepaid Expenses | 0.72 | 0.59 | 1.11 | - | - | - |
Restricted Cash | 0.78 | 0.22 | 1 | - | - | - |
Other Current Assets | - | - | - | 1.81 | 0.02 | 0.39 |
Total Current Assets | 1.49 | 0.81 | 2.11 | 1.84 | 0.08 | 0.39 |
Long-Term Investments | 0.09 | 0.09 | 3.39 | - | - | - |
Total Assets | 1.58 | 0.9 | 5.5 | 1.84 | 0.08 | 0.39 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.96 | 0.8 | 0.93 | - | 0.24 | 0.05 |
Accrued Expenses | 16.06 | 15.7 | 16.2 | 11.44 | 6.33 | 2.14 |
Short-Term Debt | 9.35 | 16.3 | 12.12 | 1.22 | 0.18 | 0.08 |
Other Current Liabilities | 0.2 | 1.09 | 0.76 | - | - | - |
Total Current Liabilities | 26.57 | 33.89 | 30.01 | 12.66 | 6.74 | 2.27 |
Long-Term Debt | 6 | 5.57 | 4.12 | - | - | - |
Other Long-Term Liabilities | 61.41 | 59.06 | 62.13 | - | - | - |
Total Liabilities | 93.98 | 98.52 | 96.26 | 12.66 | 6.74 | 2.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Additional Paid-In Capital | 121.38 | 107.92 | 105.29 | 70.77 | 57.57 | - |
Retained Earnings | -213.78 | -205.54 | -196.06 | -81.59 | -64.23 | -1.89 |
Shareholders' Equity | -92.4 | -97.62 | -90.76 | -10.82 | -6.66 | -1.89 |
Total Liabilities & Equity | 1.58 | 0.9 | 5.5 | 1.84 | 0.08 | 0.39 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 15.35 | 21.87 | 16.24 | 1.22 | 0.18 | 0.08 |
Net Cash (Debt) | -15.35 | -21.87 | -16.24 | -1.19 | -0.12 | -0.08 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.35 | -0.80 | -0.62 | -0.05 | -0.01 | -0.00 |
Filing Date Shares Outstanding | 232.37 | 166.01 | 34.82 | 23.36 | 17.5 | 17.45 |
Total Common Shares Outstanding | 166.01 | 34.87 | 34.65 | 23.36 | 17.5 | 17.45 |
Working Capital | -25.08 | -33.08 | -27.9 | -10.82 | -6.66 | -1.89 |
Book Value Per Share | -0.56 | -2.80 | -2.62 | -0.46 | -0.38 | -0.11 |
Tangible Book Value | -92.4 | -97.62 | -90.76 | -10.82 | -6.66 | -1.89 |
Tangible Book Value Per Share | -0.56 | -2.80 | -2.62 | -0.46 | -0.38 | -0.11 |